Endometrial cancer is a type of cancer that affects the lining of the uterus. It is the most common gynecologic cancer in the United States, and is typically diagnosed in women over the age of 50. Symptoms of endometrial cancer include abnormal vaginal bleeding, pelvic pain, and pain during intercourse. Treatment options for endometrial cancer include surgery, radiation therapy, chemotherapy, and hormone therapy.
The oncology market for endometrial cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are developing new drugs to target endometrial cancer, and medical device companies are developing new technologies to improve diagnosis and treatment. Additionally, research is being conducted to better understand the biology of endometrial cancer and to develop new treatments.
Companies in the endometrial cancer market include AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
